Samira Anbari

Biochemistry, Genetics and Molecular BiologyEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Using quantitative systems pharmacology modeling to optimize combination therapy of anti-PD-L1 checkpoint inhibitor and T cell engager”.

Using quantitative systems pharmacology modeling to optimize combination therapy of anti-PD-L1 checkpoint inhibitor and T cell engager

Frontiers in Pharmacology(2023)10.3389/fphar.2023.1163432

N/A

0.529DataRank · unranked

33 citations

Hanwen Wang, Yu Zhang, Jun Wang, Minu Pilvankar, Masoud Nickaeen +3 more

Identifying biomarkers for treatment of uveal melanoma by T cell engager using a QSP model

npj Systems Biology and Applications(2024)10.1038/s41540-024-00434-5

N/A

0.360DataRank · unranked

10 citations

Hanwen Wang, Theinmozhi Arulraj, Masoud Nickaeen, Minu Pilvankar, Jun Wang +3 more

Quantitative systems pharmacology modeling of macrophage‐targeted therapy combined with PD‐L1 inhibition in advanced NSCLC

Clinical and Translational Science(2024)10.1111/cts.13811

N/A

0DataRank · unranked

13 citations

Theinmozhi Arulraj, Samira Anbari, Aleksander S. Popel, Hanwen Wang